CEA (Carcinoembryonic antigen) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CEA (Carcinoembryonic antigen) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CEA (Carcinoembryonic antigen) |
| Clone | polyclonal |
| Host Species | n/a |
| Reactive Species | human |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This antibody is produced by immunizing rabbits with a synthetic peptide (KLH-coupled) corresponding to a region of human CEA. Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development. It was found that serum from individuals with colorectal carcinoma, gastric carcinoma, pancreatic carcinoma, lung carcinoma and breast carcinoma, as well as individuals with medullary thyroid carcinoma, had higher levels of CEA than healthy individuals.The best use of CEA is as a tumor marker, especially for cancers of the gastrointestinal tract. |
| Immunogen | n/a |
| Other Names | [carcinoembryonic antigen-related cell adhesion molecule 5 isoform 1 preproprotein; Carcinoembryonic antigen-related cell adhesion molecule 5; carcinoembryonic antigen-related cell adhesion molecule 5; carcinoembryonic antigen related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD_antigen: CD66e], [CEACAM5; CEACAM5; CEA; CD66e; CEA; CEA] |
| Gene, Accession # | [CEA], Gene ID: 1048, NCBI: NP_001278413.1, UniProt: P06731 |
| Catalog # | MBS857036 |
| Price | $280 |
| Order / More Info | CEA (Carcinoembryonic antigen) Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. Schrewe H., Thompson J., Bona M., Hefta L.J.F., Maruya A., Hassauer M., Shively J.E., von Kleist S., Zimmermann W.; Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression.; Mol. Cell. Biol. 10:2738-2748(1990). 2. Hirovuki O, Kazuhiro S, Haruhiko I, et al. Preoperative serum CEA level is predictive for patient outcome in case of non-small cell lung cancer, especially squamous cell carcinoma. Yokohama Med, 2005, 56(5/6):541-546. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies